1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. AMICUS THERAPEUTICS INC

Amicus Therapeutics Inc

XNAS: FOLD

Expensive Underperformer
Download real time

6.07 -0.14 (-2.25%)

Near 52W Low of $5.81

3.3M XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
8S
14W
1O
2T
1,869.1

Market Cap

High in industry
-63.6

PE TTM

Negative PE TTM
-0.8

PEG TTM

PEG TTM is negative
9.6

Price to Book

High in industry
0.0

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Amicus Therapeutics Inc is on 06 Jun 2025 for the purpose of Amicus Therapeutics Inc Annual General Meeting for 2025 See details

Amicus Therapeutics Inc - FOLD - stock price prediction, stock price target, analyst ratings from 12 analysts

Amicus Therapeutics Inc has a share price target of US$ 16, revenue growth forecast of 17.7%, and profit growth estimate of 51.1% for FY25, based on top 12 analyst calls.

Forecaster Screeners